117 related articles for article (PubMed ID: 12050044)
21. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
Sherer Y; Gerli R; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
[TBL] [Abstract][Full Text] [Related]
22. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
[TBL] [Abstract][Full Text] [Related]
23. Levels of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in healthy newborn cord sera.
Nicaise-Roland P; Aurousseau MH; Delaval A; Grootenboer-Mignot S; Hurtado M; Carbillon L; Fain O; Uzan M; Lachassine E; Boffa MC; Chollet-Martin S
Thromb Haemost; 2008 Jun; 99(6):1124-6. PubMed ID: 18521522
[No Abstract] [Full Text] [Related]
24. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study.
Ruffatti A; Del Ross T; Ciprian M; Nuzzo M; Rampudda M; Bertero MT; Bergia R; Caramaschi P; Biasi D; Capsoni F; Montaguti L; Ruffini R; Brucato A; Picillo U; Fanelli V; Riccieri V; Piccoli A; Valesini G; Doria A; Meroni PL; Tincani A
Ann Rheum Dis; 2009 Mar; 68(3):397-9. PubMed ID: 18812393
[TBL] [Abstract][Full Text] [Related]
25. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
[TBL] [Abstract][Full Text] [Related]
26. Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure.
Ozmen S; Danis R; Akin D; Batun S
Clin Nephrol; 2009 Sep; 72(3):193-8. PubMed ID: 19761724
[TBL] [Abstract][Full Text] [Related]
27. The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.
Sulik A; Kowal-Bielecka O; Domysławska I; Chwiećko J; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():228-31. PubMed ID: 16119673
[TBL] [Abstract][Full Text] [Related]
28. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
Ruffatti A; Tonello M; Cavazzana A; Bagatella P; Pengo V
Thromb Res; 2009; 123(3):482-7. PubMed ID: 18462781
[TBL] [Abstract][Full Text] [Related]
29. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid antibodies in young myocardial infarction patients.
Mishra MN; Kalra R; Gupta MK
Indian J Biochem Biophys; 2007 Dec; 44(6):481-4. PubMed ID: 18320848
[TBL] [Abstract][Full Text] [Related]
31. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?
Galli M
Thromb Res; 2004; 114(5-6):597-601. PubMed ID: 15507297
[TBL] [Abstract][Full Text] [Related]
33. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T
Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286
[TBL] [Abstract][Full Text] [Related]
34. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
35. Anticardiolipin antibodies and retinal vascular complications in Behçet's disease.
Ozdemir Y; Onder F; Yarangümeli A; Küçükkuyumcu C; Kural G
Ophthalmic Surg Lasers; 1997 Aug; 28(8):653-6. PubMed ID: 9268996
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
37. [Methods of prevention of ischemic cerebral damages in patients with antiphospholipid antibodies].
Roşca T
Oftalmologia; 2008; 52(2):72-6. PubMed ID: 19065918
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
Carbone J; Sánchez-Ramón S; Cobo-Soriano R; Seoane E; Aparicio MJ; Ruiz-Tíscar JL; Rodríguez-Mahou M; Rodríguez-Molina JJ; Sarmiento E; Cortés C; Fernández-Cruz E
J Rheumatol; 2001 Nov; 28(11):2437-41. PubMed ID: 11708415
[TBL] [Abstract][Full Text] [Related]
39. [Risk of thrombosis with increased anticardiolipin antibodies].
Winckelmann G
Dtsch Med Wochenschr; 1997 Apr; 122(15):492-3. PubMed ID: 9147943
[No Abstract] [Full Text] [Related]
40. Vascular dementia and anticardiolipin antibodies.
de Godoy JM; de Godoy MR; Cipulo JP; Tognola VA
Med Sci Monit; 2005 Sep; 11(9):CR430-3. PubMed ID: 16127362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
